Cargando…

Erectile dysfunction in nonmuscle-invasive bladder cancer patients before and after transurethral resection (TUR) of bladder tumor in China

The aim of this study was to investigate the incidence of erectile dysfunction (ED) in nonmuscle-invasive bladder cancer (NMIBC) patients before and after transurethral resection (TUR) in China. Clinical data from 165 male patients with NMIBC who received adjuvant intravesical chemotherapy after TUR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Peng, Wang, Yu, Xie, Yun-Feng, Lv, Tian-Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491038/ https://www.ncbi.nlm.nih.gov/pubmed/34747726 http://dx.doi.org/10.4103/aja202166

Ejemplares similares

Safety and efficacy of en bloc transurethral resection versus conventional transurethral resection for primary nonmuscle-invasive bladder cancer: a meta-analysis
por: Zhang, Dong, et al.
Publicado: (2020)

The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopy
por: Qie, Yunkai, et al.
Publicado: (2016)

Advances in nonmuscle invasive bladder cancer
por: Konety, Badrinath R.
Publicado: (2015)

Comparison of sterile water irrigation versus intravesical mitomycin C in preventing recurrence of nonmuscle invasive bladder cancer after transurethral resection
por: Bijalwan, Priyank, et al.
Publicado: (2017)

Tranexamic acid decreases blood loss during transurethral resection of the prostate (TUR -P)
por: Kumsar, Şükrü, et al.
Publicado: (2011)

Diagnostics techniques in nonmuscle invasive bladder cancer
por: Soubra, Ayman, et al.
Publicado: (2015)

Intravesical immunotherapy in nonmuscle invasive bladder cancer
por: Jokisch, Jan-Friedrich, et al.
Publicado: (2015)

Active surveillance for nonmuscle invasive bladder cancer
por: Miyake, Makito, et al.
Publicado: (2016)

Nonmuscle invasive bladder cancer: a primer on immunotherapy
por: Maruf, Mahir, et al.
Publicado: (2016)

New therapies in nonmuscle invasive bladder cancer treatment
por: Rayn, Kareem N., et al.
Publicado: (2018)

Management of bladder pheochromocytoma by transurethral resection
por: Sharma, Aditya P., et al.
Publicado: (2019)

Transurethral resection of bladder tumour (TURBT)
por: Kim, Lawrence H. C., et al.
Publicado: (2020)

Transurethral resection syndrome: A rare complication of intraperitoneal bladder perforation during transurethral resection of bladder tumor
por: Ibrahimi, Ahmed, et al.
Publicado: (2020)

Extraperitoneal bladder perforation secondary to transurethral resection of bladder tumor
por: Luu, Doan Tien, et al.
Publicado: (2021)

Transurethral needle electrode resection and transurethral holmium laser resection of bladder cancer
por: Zhou, Yu, et al.
Publicado: (2020)

Emerging intravesical therapies for management of nonmuscle invasive bladder cancer
por: Tomaszewski, Jeffrey J, et al.
Publicado: (2010)

The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer
por: Russell, Christopher M., et al.
Publicado: (2016)

Utility of restage transurethral resection of bladder tumor
por: Manoharan, Vignesh, et al.
Publicado: (2018)

Technical developments in transurethral resection of bladder tumours
por: Pastuszak, Agata, et al.
Publicado: (2019)

Bladder injury secondary to obturator reflex is more common with plasmakinetic transurethral resection than monopolar transurethral resection of bladder cancer
por: Ozer, Kutan, et al.
Publicado: (2015)

The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia
por: Oka, Anak Agung Gde, et al.
Publicado: (2019)

A commentary on ‘systematic review and meta-analysis of randomized controlled trials of perioperative outcomes and prognosis of transurethral en-bloc resection versus conventional transurethral resection for nonmuscle-invasive bladder cancer’ (Int J Surg 2022; 104:106777)
por: Tan, Zhiyong, et al.
Publicado: (2023)

Management of Localized Prostate Cancer by Focal Transurethral Resection of Prostate Cancer: An Application of Radical TUR-PCa to Focal Therapy
por: Morita, Masaru, et al.
Publicado: (2012)

The Role of Interferon in the Management of BCG Refractory Nonmuscle Invasive Bladder Cancer
por: Correa, Andres F., et al.
Publicado: (2015)

Optimal Treatment for Intermediate- and High-Risk, Nonmuscle-Invasive Bladder Cancer
por: van der Meijden, A.P.M.
Publicado: (2006)

Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer
por: Lilge, Lothar, et al.
Publicado: (2020)

Multivariate Analysis of the Prognostic Significance of Resection Weight after Transurethral Resection of Bladder Tumor for Non-Muscle-Invasive Bladder Cancer
por: Kwon, Dae Hyeon, et al.
Publicado: (2012)

Bladder leiomyoma treated with transurethral resection of bladder tumor (TURBT): Case report
por: AlHalak, Rouzy, et al.
Publicado: (2022)

Obturator Nerve Block for Transurethral Resection of Bladder Tumors
por: Gavrilovska-Brzanov, Aleksandra, et al.
Publicado: (2023)

Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis
por: Wu, Yu-Peng, et al.
Publicado: (2016)

Metabolomics analysis reveals distinct profiles of nonmuscle‐invasive and muscle‐invasive bladder cancer
por: Sahu, Divya, et al.
Publicado: (2017)

Bladder explosion during transurethral resection of prostate: Bladder diverticula as an additional risk factor
por: Vincent, D. Paul
Publicado: (2017)

Consensus Definition and Prediction of Complexity in Transurethral Resection or Bladder Endoscopic Dissection of Bladder Tumours
por: Roumiguié, Mathieu, et al.
Publicado: (2020)

Current and Innovative Approaches in the Treatment of Non-muscle Invasive Bladder Cancer: The Role of Transurethral Resection of Bladder Tumor and Organoids
por: Taskovska, Milena, et al.
Publicado: (2020)

Prostatic urethra recurrence after transurethral resection of bladder tumor (TURBT) for non‐muscle‐invasive bladder cancer (NMIBC)
por: Bilim, Vladimir, et al.
Publicado: (2022)

Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy
por: Miyata, Yasuyoshi, et al.
Publicado: (2015)

Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer (Erratum)
por: Lilge, Lothar, et al.
Publicado: (2020)

The use of blue-light cystoscopy in the detection and surveillance of nonmuscle invasive bladder cancer
por: Cahill, Ellen M., et al.
Publicado: (2022)

The indispensable role of urinalysis for patients undergoing treatment for nonmuscle invasive bladder cancer
por: Di Gianfrancesco, Luca, et al.
Publicado: (2022)

Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?
por: Beukers, Willemien, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ms3hmvss4ti8ulkm7k1qnnupur